Melbourne-based next generation Hyperparallel OCT manufacturer Cylite has further expanded its R&D team with the appointment of optical physicist Dr Clare Manderson.
Manderson has spent her career applying optical physics to solve problems in engineering and biomedical science by adapting and building laser-based microscopy and super-resolution imaging systems from the ground up.
According to the company, her skill set is ideally suited to OCT, with her PhD being completed in the field of coherent diffraction imaging. This involves high-resolution images reconstructed from diffraction data using a mathematical process called Fourier transformation, the same process used to reconstruct spectral-domain OCT images.
More recently, Manderson worked as part of the Blood Transfusion Diagnostics team at Monash University, where she designed and built a laser-based blood incubation chamber used for pre-transfusion blood compatibility testing.
A world-first technology, and finalist in the Australian Engineering Excellence Awards in 2020, the device was primarily designed to modernise the blood heating process in compatibility testing and prevent blood transfusion delays.
“At Cylite, Dr Manderson will be part of the team that will push the boundaries of the unique, true-3D capture capabilities of the soon-to-be-released Hyperparallel OCT device, which could prove fundamental in future medical research,” the company stated.
“With several patents already awarded to Cylite relating to this technology, the team will now begin the hard work of translating the established concepts into working prototypes, and eventually into the hands of researchers.”
Manderson added: “I’m excited to join the Cylite team because I get to work with high-end optical systems in cutting-edge eye diagnostic equipment.”